Cleared Traditional

K223625 - CapnoSpot™ Pneumothorax Decompression Indicator (FDA 510(k) Clearance)

Mar 2023
Decision
113d
Days
Class 1
Risk

K223625 is an FDA 510(k) clearance for the CapnoSpot™ Pneumothorax Decompression Indicator. This device is classified as a Needle, Aspiration And Injection, Disposable (Class I - General Controls, product code GAA).

Submitted by Pneumeric, Inc. (Rochester, US). The FDA issued a Cleared decision on March 28, 2023, 113 days after receiving the submission on December 5, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4800.

Submission Details

510(k) Number K223625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2022
Decision Date March 28, 2023
Days to Decision 113 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code GAA - Needle, Aspiration And Injection, Disposable
Device Class Class I - General Controls
CFR Regulation 21 CFR 878.4800